Predictive Biosciences names new CFO, CMO

Predictive Biosciences announced the appointment of two senior executives: Ellen Sheets, M.D., to the newly created position of chief medical officer and Vikram Lamba to the position of CFO.

ProMetic Life Sciences has named Bruce Pritchard as CFO.

XenoPort has named David A. Stamler, M.D., as CMO.

Rexahn Pharmaceuticals announced the appointment of Rick Soni as CBO.

Noven Pharmaceuticals has named Joel Lippman, M.D., as Vice President of Clinical Development & CMO.

Dr. Richard M. Soll has joined WuXi PharmaTec as VP of Medicinal Chemistry.

Synta Pharmaceuticals has chosed Michael P. Bailey as Senior Vice President and Chief Commercial Officer. 
Merck has elected Leslie Brun to its board of directors.

Znomics has named Charles N. Blitzer to board of directors.

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.